Structural Analysis of an O-Glycopeptide Derived from Recombinant Erythropoiet in by SYNAPT High Definit ion Mass Spectrometry (HDMS)

Significance of the Topic

Glycosylation represents a critical post-translational modification in many therapeutic proteins, influencing their stability, solubility, serum half-life and immunogenic profile. O-glycosylation heterogeneity and site-specific patterns on proteins such as recombinant erythropoietin must be precisely characterized to ensure product consistency, support regulatory approval and optimize therapeutic efficacy.

Objectives and Study Overview

This study demonstrates a streamlined approach to obtain both the glycan composition and attachment site of an O-linked glycopeptide from recombinant erythropoietin. By leveraging time-aligned-parallel (TAP) fragmentation in a single mass spectrometry experiment, the method aims to overcome limitations of conventional MS/MS analysis of O-glycopeptides.

Methodology and Instrumentation

Sample preparation included reduction, alkylation and tryptic digestion of recombinant EPO, followed by nanoLC separation on a Waters nanoACQUITY UPLC system with an Atlantis dC18 column. MS analysis was performed on a Waters SYNAPT HDMS system equipped with Triwave technology. TAP fragmentation involved dual-stage collision-induced dissociation: initial glycan cleavage in the TRAP T-Wave at 35 V, ion mobility separation by the IMS T-Wave, and secondary peptide backbone fragmentation in the TRANSFER T-Wave at alternating low (5 V) and high (60–100 V) collision energies.

Main Results and Discussion

The first TAP stage generated glycan-related fragments, enabling the assignment of a NeuNAc–Hex–HexNAc sequence. IMS separation provided distinct drift times for each fragment population. In the second TAP stage, high-energy CID of mobility-resolved ions produced peptide sequence ions, revealing the glycosylation site at the serine residue six residues from the C-terminus. This dual-stage approach thus simultaneously delivers glycan structure and site localization in a single analytical run.

Benefits and Practical Applications of the Method

• Rapid, site-specific characterization of O-glycopeptides without enzymatic deglycosylation.
• Improved confidence in glycan composition and attachment site assignments.
• Enhanced capability for quality control and regulatory compliance of glycoprotein therapeutics.
• Potential to streamline characterization workflows in biopharmaceutical development.

Future Trends and Potential Applications

Integration of TAP fragmentation with advanced bioinformatics tools and high-throughput IMS-MS platforms could further accelerate glycoprotein analysis. This approach may be extended to complex glycopeptide mixtures, multiplexed analyses and other classes of post-translational modifications. Continued development of ion mobility technologies promises deeper insights into glycan isomer separation and structural elucidation.

Conclusion

The time-aligned-parallel fragmentation strategy on the SYNAPT HDMS platform effectively unites glycan sequencing and site-specific localization of O-glycopeptides in a single experiment. This methodology enhances the structural characterization of therapeutic glycoproteins, supporting immunogenicity assessment, batch consistency and regulatory requirements.

References

• Medzihradszky KF. Methods Enzymol. 405, 116–138 (2005).
• Kirchner S. U.S. Patent 5,206,506 (1993).
• Sasaki H, Ochi N, Dell A, Fukuda M. Biochemistry. 1988;27:8618–8626.